AliveCor develops AI-enabled ECG devices, including the FDA-cleared KardiaMobile 6L, which provides real-time detection of various heart conditions such as Atrial Fibrillation and Bradycardia. The platform enhances remote cardiac care by allowing patients to monitor their heart health and share data with healthcare providers, addressing the need for continuous heart rhythm management outside clinical settings.
Funding
Funding not disclosed
GHFounders
Product
Problem
Traditional ECG monitoring often requires in-clinic visits, limiting continuous heart rhythm assessment and timely detection of cardiac events outside of healthcare facilities. This can delay diagnosis and management of intermittent heart conditions, impacting patient outcomes and increasing healthcare costs.
Solution
AliveCor provides AI-powered, portable ECG devices, including the KardiaMobile 6L and Kardia 12L, that enable real-time heart condition detection and monitoring anywhere. These devices allow patients to record medical-grade ECGs and share data with healthcare providers, facilitating remote cardiac care and proactive heart health management. AliveCor's solutions extend to health systems, biopharma companies, payers, and employers, offering tools for comprehensive cardiac monitoring and improved patient care coordination. The platform leverages machine learning to analyze heart rhythm data, providing insights that support timely interventions and reduce the burden of heart disease.
Target Audience
The primary target audience includes individual patients seeking convenient heart health monitoring, healthcare professionals requiring real-time cardiac data analysis, and health systems aiming to improve remote patient care and reduce costs associated with heart disease.
Features
- KardiaMobile 6L: A personal ECG device that detects Atrial Fibrillation, Bradycardia, Tachycardia, and Normal Sinus Rhythm in 30 seconds.
- Kardia 12L: A 12-lead portable ECG for healthcare professional use, providing comprehensive cardiac data acquisition.
- AI-enabled ECG analysis for real-time detection of various heart conditions.
- Data integration solutions for seamless connectivity with existing healthcare workflows.
- Remote patient monitoring capabilities for continuous heart rhythm assessment outside clinical settings.
- Enterprise platform for health systems to remotely track patients' heart rhythm data.
- Solutions for biopharma partners to advance disease and safety monitoring.